These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21706033)

  • 21. Inhibitors of HIV-1 Tat-mediated transactivation.
    Richter SN; Palù G
    Curr Med Chem; 2006; 13(11):1305-15. PubMed ID: 16712471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
    Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(ADP-ribose) polymerase-1 is a negative regulator of HIV-1 transcription through competitive binding to TAR RNA with Tat.positive transcription elongation factor b (p-TEFb) complex.
    Parent M; Yung TM; Rancourt A; Ho EL; Vispé S; Suzuki-Matsuda F; Uehara A; Wada T; Handa H; Satoh MS
    J Biol Chem; 2005 Jan; 280(1):448-57. PubMed ID: 15498776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of RNA-targeting macrocyclic peptides.
    Walker MJ; Varani G
    Methods Enzymol; 2019; 623():339-372. PubMed ID: 31239053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artificial nucleobase-amino acid conjugates: a new class of TAR RNA binding agents.
    Joly JP; Mata G; Eldin P; Briant L; Fontaine-Vive F; Duca M; Benhida R
    Chemistry; 2014 Feb; 20(7):2071-9. PubMed ID: 24431237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication.
    Narayan V; Ravindra KC; Chiaro C; Cary D; Aggarwal BB; Henderson AJ; Prabhu KS
    J Mol Biol; 2011 Jul; 410(5):972-83. PubMed ID: 21763500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactions.
    O'Brien WA; Sumner-Smith M; Mao SH; Sadeghi S; Zhao JQ; Chen IS
    J Virol; 1996 May; 70(5):2825-31. PubMed ID: 8627756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein/TAR RNA complexes required for HIV-1 transcription.
    Mei HY; Mack DP; Galan AA; Halim NS; Heldsinger A; Loo JA; Moreland DW; Sannes-Lowery KA; Sharmeen L; Truong HN; Czarnik AW
    Bioorg Med Chem; 1997 Jun; 5(6):1173-84. PubMed ID: 9222511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antiviral activity of ethidium-arginine conjugates directed against the TAR RNA of HIV-1.
    Peytou V; Condom R; Patino N; Guedj R; Aubertin AM; Gelus N; Bailly C; Terreux R; Cabrol-Bass D
    J Med Chem; 1999 Oct; 42(20):4042-53. PubMed ID: 10514274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking HIV replication by targeting Tat protein.
    Hamy F; Gelus N; Zeller M; Lazdins JL; Bailly C; Klimkait T
    Chem Biol; 2000 Sep; 7(9):669-76. PubMed ID: 10980447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel RNA motif that binds efficiently and specifically to the Ttat protein of HIV and inhibits the trans-activation by Tat of transcription in vitro and in vivo.
    Yamamoto R; Katahira M; Nishikawa S; Baba T; Taira K; Kumar PK
    Genes Cells; 2000 May; 5(5):371-88. PubMed ID: 10886365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
    Richter S; Cao H; Rana TM
    Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
    Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
    Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication.
    Harrich D; Mavankal G; Mette-Snider A; Gaynor RB
    J Virol; 1995 Aug; 69(8):4906-13. PubMed ID: 7609059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription.
    Bohjanen PR; Colvin RA; Puttaraju M; Been MD; Garcia-Blanco MA
    Nucleic Acids Res; 1996 Oct; 24(19):3733-8. PubMed ID: 8871552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
    Yang M
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dynamics and MM/GBSA-integrated protocol probing the correlation between biological activities and binding free energies of HIV-1 TAR RNA inhibitors.
    Peddi SR; Sivan SK; Manga V
    J Biomol Struct Dyn; 2018 Feb; 36(2):486-503. PubMed ID: 28081678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TAR RNA recognition by a cyclic peptidomimetic of Tat protein.
    Leeper TC; Athanassiou Z; Dias RL; Robinson JA; Varani G
    Biochemistry; 2005 Sep; 44(37):12362-72. PubMed ID: 16156649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 TAR RNA: the target of molecular interactions between the virus and its host.
    Bannwarth S; Gatignol A
    Curr HIV Res; 2005 Jan; 3(1):61-71. PubMed ID: 15638724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron(II) supramolecular helicates interfere with the HIV-1 Tat-TAR RNA interaction critical for viral replication.
    Malina J; Hannon MJ; Brabec V
    Sci Rep; 2016 Jul; 6():29674. PubMed ID: 27405089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.